Cannabis

Cannabis Law360 provides breaking news and analysis of emerging and evolving legal issues surrounding cannabis. Coverage ranges from regulatory and policy concerns facing the industry to the business of lawyers who counsel cannabis companies. Among the practice areas covered are intellectual property, mergers & acquisitions and employment.



Sign up for a 7-day FREE trial today!



Latest News in Cannabis

  • April 28, 2026

    Anti-Pot Group Says CMS Violated APA With Hemp Program

    A group of advocates opposed to legal cannabis, as well as a cannabinoid company and two individuals, are fighting the government's bid to halt their challenge to a program to give Medicare beneficiaries access to federally legal hemp products, saying the Centers for Medicare & Medicaid Services violated federal law by instituting the program without notice or comment.

  • April 27, 2026

    Altria, Juul Can Appeal Class Cert. Decision In Antitrust Suit

    The Ninth Circuit on Monday granted Altria and Juul's request to appeal a ruling certifying several classes of e-cigarette buyers in an antitrust case alleging the companies schemed to have Altria exit the e-cigarette market.

  • April 27, 2026

    CBD Brewing Co. Can't Escape Trade Secrets Suit

    A Minnesota brewery cannot escape a beverage startup's fraud and trade secrets lawsuit, a federal court has ruled, ordering more discovery after a jury delivered a $1.8 million verdict in a separate case in which the co-founder admitted to faking paperwork.

  • April 27, 2026

    Attys, Advocates Call DOJ Pot Rule Historic Shift For Feds

    Legal strategies are evolving quickly in the wake of last week's "historic" rescheduling of state-legal medical cannabis, as a group of attorneys and advocates gathered Monday to evaluate the trade-offs of dispensaries now being able to register like pharmacies with the feds and the potential effect on industry investments and trade.

  • April 27, 2026

    Cannabis Co. Can't Shift Atty AI Sanctions To Rival Company

    A Florida federal judge will not force a medical marijuana company to accept liability for sanctions incurred by its in-house counsel over the misuse of generative artificial intelligence, rejecting a rival company's arguments that the lawyer previously avoided monetary sanctions for filing errors and was likely to do so again.

See more Cannabis news

Cannabis

Areas of Coverage

  • AGENCIES
  • U.S. Food & Drug Administration
  • Federal Trade Commission
  • Drug Enforcement Agency
  • U.S. Department of the Treasury
  • California Bureau of Cannabis Control
  • Department of Health & Human Services
  • Financial Crimes Enforcement Network
  • U.S. Securities and Exchange Commission
  • U.S. Commodity Futures Trading Commission
  • U.S. Department of Justice
  • State and international regulators
  • POLICY & REGULATION
  • SAFE Banking Act
  • STATES Act
  • Marijuana Opportunity Reinvestment and Expungement, or MORE, Act
  • Section 280E of the Internal Revenue Code
  • Rohrabacher–Farr amendment
  • Bank Secrecy Act
  • Federal and state legislation
  • ENFORCEMENT
  • FDA and FTC actions over cannabis’s purported health claims
  • IRS actions against cannabis companies
  • Antitrust investigations
  • Financial regulatory actions
  • Federal criminal matters
  • State enforcement actions
  • LITIGATION
  • Civil RICO actions brought against cannabis concerns
  • Employment disputes
  • Securities class actions
  • Intellectual property matters
  • Consumer class actions
  • Bankruptcy
  • Tax disputes
  • Challenges to federal or state regulations
  • TRANSACTIONS
  • M&A activity involving cannabis companies
  • Commercial real estate transactions
  • PROFILES
  • Personnel moves
  • Profiles of law firm cannabis practices
  • Federal and state policymakers and lawmakers
  • General counsel interviews

READERSHIP

  • Cannabis lawyers at large to medium-sized law firms and boutiques
  • In-house counsel, compliance officers and executives at cannabis companies
  • Counsel and executives at venture capital and investment firms
  • Policymakers at federal and state agencies
  • Federal and state lawmakers
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.